| Exploring Virtual Reality Adventure Training Exergaming | N/A | The University of Texas at Arlington | <1 mi |
| Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder | Phase 2 | Intra-Cellular Therapies, Inc. | <1 mi |
| A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage) | Phase 3 | Definium Therapeutics US, Inc. | <1 mi |
| P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety | Phase 3 | Otsuka Pharmaceutical Development & Commercialization, Inc. | <1 mi |
| Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4) | Phase 3 | VistaGen Therapeutics, Inc. | <1 mi |
| Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity. | Phase 3 | Jasper A. Smits | <1 mi |
| A Study of NTX-1472 in Social Anxiety Disorder | Phase 2 | Newleos Therapeutics, Inc. | <1 mi |
| Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety | N/A | University of Texas at Austin | <1 mi |
| CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy | N/A | University of Texas at Austin | <1 mi |
| Testing FIRST in Youth Outpatient Psychotherapy | N/A | Harvard University | <1 mi |
| A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) | Phase 3 | Definium Therapeutics US, Inc. | <1 mi |
| Mitigating PTSD-CUD After Sexual Assault | Phase 1/2 | University of Nevada, Las Vegas | <1 mi |
| Clinical Trial on Agitation in Alzheimer's Dementia | Phase 2 | IGC Pharma, LLC | <1 mi |
| RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses | Phase 2 | Reunion Neuroscience Inc | <1 mi |
| Wellness App for Sleep Disturbance in Hematological Cancer Patients | N/A | The University of Texas Health Science Center at San Antonio | <1 mi |
| Cognitive Behavioral Intervention to Reduce Procedural Anxiety Among Woman With High Risk Pregnancies With Scheduled Cesarean Deliveries | N/A | University of Colorado, Denver | <1 mi |
| Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes | — | M.D. Anderson Cancer Center | <1 mi |
| Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity | N/A | Deliberate Solutions Inc. | <1 mi |
| Neonatal Neurodevelopmental Outcomes | — | Baylor College of Medicine | <1 mi |
| A Neurosensory Account of Anxiety and Stress (Study 1) | N/A | The University of Texas Health Science Center, Houston | <1 mi |
| CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD | N/A | Baylor College of Medicine | <1 mi |
| Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors | N/A | M.D. Anderson Cancer Center | <1 mi |
| Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety | N/A | Baylor College of Medicine | <1 mi |
| Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder | Phase 3 | Vanda Pharmaceuticals | <1 mi |
| Neurophysiological Investigation of the Approach-avoidance Axis in OCD: Applications to Neuromodulation | — | Baylor College of Medicine | <1 mi |
| Personalized Feedback Intervention for Latinx Drinkers With Anxiety | N/A | University of Houston | <1 mi |
| Integrated CBT to Improve Functioning in Veterans With Anxiety and Substance Use | N/A | VA Office of Research and Development | <1 mi |
| Enhancing Psychotherapy for Veterans and Service Members With PTSD and Anxiety | N/A | Baylor College of Medicine | <1 mi |
| Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD | N/A | Baylor College of Medicine | <1 mi |
| Stepped Care Treatment for Anxiety Resilience | N/A | Andrew Wiese | <1 mi |
| Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus | N/A | Christina Chianis Reed | <1 mi |
| ERP to Improve Functioning in Veterans With OCD | N/A | VA Office of Research and Development | <1 mi |
| A Neurosensory Account of Anxiety and Stress (Study 2) | N/A | The University of Texas Health Science Center, Houston | <1 mi |
| A Mobile Intervention for Black Individuals Who Engage in Hazardous Drinking | N/A | University of Houston | <1 mi |
| Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety | N/A | Michael J. Zvolensky, Ph.D. | <1 mi |
| Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer | Phase 2/3 | M.D. Anderson Cancer Center | <1 mi |
| Pilot Study of Virtual Reality Therapy for Students With Anxiety | N/A | The University of Texas Health Science Center, Houston | <1 mi |
| Application of Virtual Reality Technology to Treatment of Social Anxiety | N/A | The University of Texas Health Science Center, Houston | <1 mi |
| Recovery Through Inspiration, Support, and Empowerment | N/A | University of Texas Southwestern Medical Center | <1 mi |
| Resilience in Adolescent Development | — | University of Texas Southwestern Medical Center | <1 mi |
| Teen Recovery Through Inspiration, Support, and Empowerment | N/A | University of Texas Southwestern Medical Center | <1 mi |
| Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder | Phase 2 | AbbVie | <1 mi |
| Measurement-Based Peer Supervision App for Non-Specialist Providers | N/A | Dimagi Inc. | <1 mi |
| Targeting Social Function in Anxiety and Eating Disorders | N/A | University of Texas Southwestern Medical Center | <1 mi |
| Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder | Phase 2 | Intra-Cellular Therapies, Inc. | <1 mi |
| Massage Therapy After Thoracic or Lumbar Surgery | N/A | Cook Children's Health Care System | 2 mi |
| Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma | N/A | Memorial Sloan Kettering Cancer Center | 6 mi |
| A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study) | Phase 2 | Seaport Therapeutics | 9 mi |
| GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia | Phase 2 | Syndeio Biosciences, Inc | 13 mi |
| TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age | — | State University of New York at Buffalo | 18 mi |
| A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder | Phase 2 | VistaGen Therapeutics, Inc. | 18 mi |